FULC · Fulcrum Therapeutics, Inc.
$3.68
+0.06 (+1.66%)
At close · Jul 21
Market Cap
$246.54M
Shares
66.63M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-02-01 | $100,000,000 | — | — | — | 10-Q , filed 2026-04-27 |
Key facts
CIK
1680581
CUSIP
359616109
13F (30d)
16 filings
16 filers
Visit website
Investor relations